CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study
Clinical trial NCT04552704 · TERMINATED
Trial details
- NCT number
- NCT04552704
- Sponsor
- Tianhong Li
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2021-02-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.